The UK government has announced that the 2026 payment rate for newer medicines under the Voluntary Scheme for Branded ...

US AI-focused start-up Formation Bio has entered a deal with Lynk Pharmaceuticals for worldwide rights, excluding Greater ...

A senior-level conference focused on the strategies and operating models shaping the next phase of the biopharma industry.

US healthcare giant Johnson & Johnson has announced new data from the investigational Phase III MajesTEC-3 study showing the ...

Clinical-stage biotech D3 Bio announced the completion of a $108 million Series B financing round, adding to the continuous ...

Swiss pharma giant Novartis’ has announced results showing that one in four patients with hormone receptor-positive, human ...

The US regulator has approved Waskyra (etuvetidigene autotemcel), the first gene-correcting therapy for Wiskott-Aldrich ...

Headquartered in Antwerp, Belgium, with an additional site in Denmark (Aarhus). The company is developing macrophage-targeted ...

Chinese biotech dominance and opportunities for Western companies to stay competitive have been highlighted in surveys released by clinical research organization ICON.

The US Food and Drug Administration has approved a US-manufactured version of Augmentin XR (amoxicillin-clavulanate potassium) through its new Commissioner’s National Priority Voucher pilot, ...

The US Food and Drug Administration (FDA) yesterday issued the final guidance, “Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Products, and ...

Vinay Prasad, director of the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER), ...